Rajangam Kanya
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Rajangam Kanya. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| SNTI | Pres. & Chief Med. & Dev. Off. | C | 33,000 | $2.25 | $74,250 | Mar 10, 2025 |
| SNTI | Pres. & Chief Med. & Dev. Off. | Award / Grant | 78,363 | — | — | Mar 7, 2025 |
| SNTI | Pres. & Chief Med. & Dev. Off. | Sale | 182 | $4.37 | $795 | Feb 4, 2025 |
| SNTI | Chief Medical & Devt. Officer | Award / Grant | 101,000 | — | — | Feb 1, 2024 |
| NKTX | Chief Medical Officer | Award / Grant | 12,800 | — | — | Jan 14, 2022 |
| NKTX | Chief Medical Officer | Sale | 10,000 | $37.28 | $372,800 | Aug 5, 2021 |